
Nature leads
Courtesy of Laura Micheli. © Epitech Group SpA
COMMITMENT AND VISION
Over 30 years of scientific research
We have been following the progress of neuroscience since the 1990s, focusing in particular on the pathophysiological mechanisms of neuroinflammation and the possibility of modulating them ‘as nature intended’ in order to benefit health.

Ideas

Responsibility

Know-how
neuroinflammation & More
News and insights
PEA: biomarker and promising modulator of neurobiological processes in ASD
The large study published in Molecular Autism (Aran et al., 2019) examined circulating endocannabinoids levels…
First “Excellence in Neuroinflammation” Meeting
We announce that the first Excellence in Neuroinflammation Meeting will take place on Saturday, October…
392 patents achieved after more than 30 years of scientific activity
In 2024 we confirmed our commitment to R&D, by strengthening our collaborations with the most…
frontier research
Looking beyond neurones
Scientific evidence from various sources is encouraging us to explore different biopharmacological research pathways in order to investigate the key role of certain non-neuronal immune cells in the pathogenesis of many disorders of neuroinflammatory origin.